Markets › LSE › ABDX.L

Abingdon Health Plc

LSE:ABDX.LHealthcareFTSE:AXX

£0.0900+0.00%At closeAt close · Tue 20 Oct · ≈ AED 0.4401 · Market cap $30.29M · Next earnings Wed 18 Nov

GBP millions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Net income	(7.0)	(21.3)	(3.5)	(1.3)	(3.4)	—	—
Depreciation & amortization	0.7	1.6	0.7	0.4	0.6	0.7	+20.1%
Stock-based compensation	1.4	0.2	0.0	0.0	0.2	—	—
Change in working capital	(8.2)	(5.4)	3.7	(0.7)	(0.5)	0.4	+165.5%
Operating cash flow	(12.9)	(7.7)	1.0	(1.7)	(3.1)	(1.6)	+48.6%
Capital expenditure	(7.3)	(0.8)	(0.2)	(0.0)	(0.3)	(0.2)	+38.5%
Acquisitions	(0.0)	(0.0)	0.0	0.0	(1.2)	—	—
Investing cash flow	(7.3)	(0.8)	(0.2)	(0.0)	(1.4)	—	—
Dividends paid	0.0	0.0	0.0	0.0	0.0	—	—
Share buybacks	0.0	0.0	0.0	0.0	0.0	—	—
Debt issued / repaid	0.3	0.0	(0.0)	(0.1)	0.0	—	—
Financing cash flow	20.7	5.9	(0.0)	(0.1)	5.1	—	—
Free cash flow	(20.1)	(8.5)	0.8	(1.7)	(3.4)	(1.8)	+47.9%
Net change in cash	0.6	(2.6)	0.8	(1.8)	0.5	—	—